LTR PHARMA LIMITED - Announcements

3.80%

41.0¢

Market Cap $71.80M

Healthcare Biotechnology

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Announcements

Filter Results

All Price Sensitive Only

LTP	Investor Presentation		11/03/26	2.22MB	Share
LTP	SPONTAN Phase II Clinical Study Completes Recruitment	PRICE SENSITIVE	05/03/26	149.67KB	Share
LTP	Appendix 4D and Half Yearly Report	PRICE SENSITIVE	26/02/26	11.77MB	Share
LTP	Application for quotation of securities - LTP		10/02/26	15.81KB	Share
LTP	SPONTAN Shows Positive Outcomes in Younger Men with ED	PRICE SENSITIVE	02/02/26	458.06KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/26	281.69KB	Share
LTP	First Patients Dosed in SPONTAN Phase II Clinical Study	PRICE SENSITIVE	22/01/26	127.68KB	Share
LTP	Application for quotation of securities - LTP		21/01/26	15.81KB	Share
LTP	Notification regarding unquoted securities - LTP		16/01/26	17.62KB	Share
LTP	Patient Recruitment Commences for SPONTAN Phase II Study		13/01/26	107.38KB	Share
LTP	SPONTAN Phase 1 Study Accepted for WMSM 2026 Podium		08/01/26	453.7KB	Share
LTP	Notification regarding unquoted securities - LTP		22/12/25	23.62KB	Share
LTP	LTR Pharma Surpasses 1,000 SPONTAN Prescriptions		17/12/25	130.81KB	Share
LTP	Application for quotation of securities - LTP		11/12/25	14.25KB	Share
LTP	TGA Provides Regulatory Clearance for SPONTAN Phase II	PRICE SENSITIVE	10/12/25	145.93KB	Share
LTP	Ethics Approval Received for SPONTAN Phase II Clinical Study	PRICE SENSITIVE	03/12/25	131.72KB	Share
LTP	Release of Restricted Securities from ASX Mandatory Escrow		02/12/25	102.98KB	Share
LTP	Change of Director's Interest Notice - M McGuire		20/11/25	1014.92KB	Share
LTP	Change of Director's Interest Notice - J Chick		20/11/25	255.24KB	Share
LTP	Change of Director's Interest Notice - L Rodne		20/11/25	255.92KB	Share
LTP	Notification regarding unquoted securities - LTP		20/11/25	16.41KB	Share
LTP	Notification regarding unquoted securities - LTP		20/11/25	17.9KB	Share
LTP	Application for quotation of securities - LTP		20/11/25	15.7KB	Share
LTP	Bell Potter Healthcare conference presentation		19/11/25	1.63MB	Share
LTP	Investor Presentation		30/10/25	2.24MB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/25	1.14MB	Share
LTP	Results of Meeting		24/10/25	108.35KB	Share
LTP	AGM Presentation		24/10/25	1.75MB	Share
LTP	LTR increases LevOmega stake to 43% with $1m investment	PRICE SENSITIVE	06/10/25	529.82KB	Share
LTP	Application for quotation of securities - LTP		26/09/25	15.76KB	Share
LTP	Notice of Annual General Meeting/Proxy Form		23/09/25	914.18KB	Share
LTP	LTR Pharma secures 33% ownership in LevOmega Pty Ltd	PRICE SENSITIVE	22/09/25	1.15MB	Share
LTP	FY25 Results Announcement	PRICE SENSITIVE	29/08/25	156.91KB	Share
LTP	Appendix 4G and Corporate Governance Statement		29/08/25	456.07KB	Share
LTP	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	29/08/25	8.64MB	Share
LTP	SPONTAN Case Series - Strong Post-Prostatectomy Results	PRICE SENSITIVE	25/08/25	146.1KB	Share
LTP	18-Month Shelf Life Strengthens SPONTAN Commercialisation	PRICE SENSITIVE	22/08/25	146.52KB	Share
LTP	SPONTAN 5x Faster Onset Validated in EU Journal	PRICE SENSITIVE	20/08/25	153.49KB	Share
LTP	US ED Specialist Dr Sun Joins LTR Advisory Board		18/08/25	143KB	Share
LTP	US ED Specialist Dr Pearlman Joins LTR Advisory Board		11/08/25	145.3KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	323.89KB	Share
LTP	Proposed issue of securities - LTP		29/07/25	16.59KB	Share
LTP	Notification regarding unquoted securities - LTP		14/07/25	17.73KB	Share
LTP	LTP Completes Extractables Study Milestone for SPONTAN	PRICE SENSITIVE	30/06/25	150.21KB	Share
LTP	Urological Expert Appointed to LTR Scientific Advisory Board	PRICE SENSITIVE	21/05/25	124.11KB	Share
LTP	SPONTAN Expands Patient Access via National Pharmacy Network	PRICE SENSITIVE	20/05/25	122.18KB	Share
LTP	LTR Signs Collaborative Agreement to Develop OMD Nasal Spray	PRICE SENSITIVE	08/05/25	157.97KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	357.78KB	Share
LTP	Change of Registered Office Address		04/04/25	106.2KB	Share
LTP	Change of Company Secretary		01/04/25	106.8KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	27/03/25	2.41MB	Share
LTP	Commercial Update and Regulatory Progress	PRICE SENSITIVE	26/03/25	143.08KB	Share
LTP	LTR Pharma to Showcase SPONTAN Data at Urology Conference	PRICE SENSITIVE	28/02/25	144.22KB	Share
LTP	Appendix 4D and Half Yearly Report	PRICE SENSITIVE	27/02/25	14.02MB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	366.1KB	Share
LTP	LTR Signs Symbion National Pharmacy Distribution Agreement	PRICE SENSITIVE	22/01/25	145.13KB	Share
LTP	Response to ASX Query Letters	PRICE SENSITIVE	30/12/24	1.52MB	Share
LTP	Agreement with Men's Health Pharmacy for SPONTAN access	PRICE SENSITIVE	19/12/24	148.1KB	Share
LTP	Cleansing Notice		17/12/24	96.46KB	Share
LTP	Application for quotation of securities - LTP		17/12/24	15.53KB	Share
LTP	Early Launch of Online Mens Health Platform	PRICE SENSITIVE	12/12/24	128.77KB	Share
LTP	Change of Company Secretary		11/12/24	75KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	10/12/24	2.96MB	Share
LTP	Proposed issue of securities - LTP		10/12/24	15.7KB	Share
LTP	LTR Pharma Announces Successful A$25 million Placement	PRICE SENSITIVE	10/12/24	141.72KB	Share
LTP	Change of Director's Interest Notices		09/12/24	608.08KB	Share
LTP	Notification regarding unquoted securities - LTP		09/12/24	18.85KB	Share
LTP	Trading Halt	PRICE SENSITIVE	06/12/24	524.84KB	Share
LTP	Ord Minnett Biotechnology Conference Presentation		28/11/24	1.87MB	Share
LTP	Results of Meeting		27/11/24	92.61KB	Share
LTP	AGM Presentation		27/11/24	1.59MB	Share
LTP	JV with Leading Men's Health Group for Online Platform	PRICE SENSITIVE	12/11/24	146.82KB	Share
LTP	Annual Report to shareholders		28/10/24	2.7MB	Share
LTP	Notice of Annual General Meeting/Proxy Form		28/10/24	398.61KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/24	335.55KB	Share
LTP	SPONTAN Final Study Results	PRICE SENSITIVE	14/10/24	148.78KB	Share
LTP	Appendix 4G and Corporate Governance Statement		30/08/24	449.98KB	Share
LTP	FY24 Results Announcement	PRICE SENSITIVE	30/08/24	126.85KB	Share
LTP	Appendix 4E and Annual Financial Report	PRICE SENSITIVE	30/08/24	2.08MB	Share
LTP	SPONTAN Prescribed to First Patient by Authorised Prescriber	PRICE SENSITIVE	16/08/24	146.22KB	Share
LTP	LTP Secures Global CoDevelopment Agreement with Aptar Pharma	PRICE SENSITIVE	13/08/24	129.33KB	Share
LTP	Mens Health Expert Prescribes SPONTAN	PRICE SENSITIVE	08/08/24	157.72KB	Share
LTP	SPONTAN prescribed to First Patient Under TGA	PRICE SENSITIVE	05/08/24	162.37KB	Share
LTP	Cleansing Notice		31/07/24	77.2KB	Share
LTP	Application for quotation of securities - LTP		31/07/24	15.53KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/24	293.5KB	Share
LTP	Investor Webinar		24/07/24	79.53KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	24/07/24	2.56MB	Share
LTP	Proposed issue of securities - LTP		24/07/24	15.29KB	Share
LTP	LTR Pharma completes A$10.5 million placement	PRICE SENSITIVE	24/07/24	136.66KB	Share
LTP	Trading Halt	PRICE SENSITIVE	22/07/24	162.76KB	Share
LTP	Reinstatement to quotation	PRICE SENSITIVE	07/06/24	85.61KB	Share
LTP	SPONTAN achieves positive clinical study results	PRICE SENSITIVE	07/06/24	209.2KB	Share
LTP	Suspension from Quotation	PRICE SENSITIVE	06/06/24	163.11KB	Share
LTP	Trading Halt	PRICE SENSITIVE	04/06/24	194.58KB	Share
LTP	Response to ASX Price Query	PRICE SENSITIVE	22/05/24	235.89KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	311.04KB	Share
LTP	Notification regarding unquoted securities - LTP		18/04/24	23.65KB	Share
LTP	Final Patients dosed in SPONTAN pivotal study	PRICE SENSITIVE	25/03/24	133.61KB	Share
LTP	First patients dosed in SPONTAN pivotal study	PRICE SENSITIVE	19/03/24	156.8KB	Share

LTP Investor Presentation
11/03/26		2.22MB	Share
LTP SPONTAN Phase II Clinical Study Completes Recruitment
05/03/26	PRICE SENSITIVE	149.67KB	Share
LTP Appendix 4D and Half Yearly Report
26/02/26	PRICE SENSITIVE	11.77MB	Share
LTP Application for quotation of securities - LTP
10/02/26		15.81KB	Share
LTP SPONTAN Shows Positive Outcomes in Younger Men with ED
02/02/26	PRICE SENSITIVE	458.06KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
28/01/26	PRICE SENSITIVE	281.69KB	Share
LTP First Patients Dosed in SPONTAN Phase II Clinical Study
22/01/26	PRICE SENSITIVE	127.68KB	Share
LTP Application for quotation of securities - LTP
21/01/26		15.81KB	Share
LTP Notification regarding unquoted securities - LTP
16/01/26		17.62KB	Share
LTP Patient Recruitment Commences for SPONTAN Phase II Study
13/01/26		107.38KB	Share
LTP SPONTAN Phase 1 Study Accepted for WMSM 2026 Podium
08/01/26		453.7KB	Share
LTP Notification regarding unquoted securities - LTP
22/12/25		23.62KB	Share
LTP LTR Pharma Surpasses 1,000 SPONTAN Prescriptions
17/12/25		130.81KB	Share
LTP Application for quotation of securities - LTP
11/12/25		14.25KB	Share
LTP TGA Provides Regulatory Clearance for SPONTAN Phase II
10/12/25	PRICE SENSITIVE	145.93KB	Share
LTP Ethics Approval Received for SPONTAN Phase II Clinical Study
03/12/25	PRICE SENSITIVE	131.72KB	Share
LTP Release of Restricted Securities from ASX Mandatory Escrow
02/12/25		102.98KB	Share
LTP Change of Director's Interest Notice - M McGuire
20/11/25		1014.92KB	Share
LTP Change of Director's Interest Notice - J Chick
20/11/25		255.24KB	Share
LTP Change of Director's Interest Notice - L Rodne
20/11/25		255.92KB	Share
LTP Notification regarding unquoted securities - LTP
20/11/25		16.41KB	Share
LTP Notification regarding unquoted securities - LTP
20/11/25		17.9KB	Share
LTP Application for quotation of securities - LTP
20/11/25		15.7KB	Share
LTP Bell Potter Healthcare conference presentation
19/11/25		1.63MB	Share
LTP Investor Presentation
30/10/25		2.24MB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/10/25	PRICE SENSITIVE	1.14MB	Share
LTP Results of Meeting
24/10/25		108.35KB	Share
LTP AGM Presentation
24/10/25		1.75MB	Share
LTP LTR increases LevOmega stake to 43% with $1m investment
06/10/25	PRICE SENSITIVE	529.82KB	Share
LTP Application for quotation of securities - LTP
26/09/25		15.76KB	Share
LTP Notice of Annual General Meeting/Proxy Form
23/09/25		914.18KB	Share
LTP LTR Pharma secures 33% ownership in LevOmega Pty Ltd
22/09/25	PRICE SENSITIVE	1.15MB	Share
LTP FY25 Results Announcement
29/08/25	PRICE SENSITIVE	156.91KB	Share
LTP Appendix 4G and Corporate Governance Statement
29/08/25		456.07KB	Share
LTP Appendix 4E and Annual Report to Shareholders
29/08/25	PRICE SENSITIVE	8.64MB	Share
LTP SPONTAN Case Series - Strong Post-Prostatectomy Results
25/08/25	PRICE SENSITIVE	146.1KB	Share
LTP 18-Month Shelf Life Strengthens SPONTAN Commercialisation
22/08/25	PRICE SENSITIVE	146.52KB	Share
LTP SPONTAN 5x Faster Onset Validated in EU Journal
20/08/25	PRICE SENSITIVE	153.49KB	Share
LTP US ED Specialist Dr Sun Joins LTR Advisory Board
18/08/25		143KB	Share
LTP US ED Specialist Dr Pearlman Joins LTR Advisory Board
11/08/25		145.3KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	323.89KB	Share
LTP Proposed issue of securities - LTP
29/07/25		16.59KB	Share
LTP Notification regarding unquoted securities - LTP
14/07/25		17.73KB	Share
LTP LTP Completes Extractables Study Milestone for SPONTAN
30/06/25	PRICE SENSITIVE	150.21KB	Share
LTP Urological Expert Appointed to LTR Scientific Advisory Board
21/05/25	PRICE SENSITIVE	124.11KB	Share
LTP SPONTAN Expands Patient Access via National Pharmacy Network
20/05/25	PRICE SENSITIVE	122.18KB	Share
LTP LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
08/05/25	PRICE SENSITIVE	157.97KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	357.78KB	Share
LTP Change of Registered Office Address
04/04/25		106.2KB	Share
LTP Change of Company Secretary
01/04/25		106.8KB	Share
LTP Investor Presentation
27/03/25	PRICE SENSITIVE	2.41MB	Share
LTP Commercial Update and Regulatory Progress
26/03/25	PRICE SENSITIVE	143.08KB	Share
LTP LTR Pharma to Showcase SPONTAN Data at Urology Conference
28/02/25	PRICE SENSITIVE	144.22KB	Share
LTP Appendix 4D and Half Yearly Report
27/02/25	PRICE SENSITIVE	14.02MB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	366.1KB	Share
LTP LTR Signs Symbion National Pharmacy Distribution Agreement
22/01/25	PRICE SENSITIVE	145.13KB	Share
LTP Response to ASX Query Letters
30/12/24	PRICE SENSITIVE	1.52MB	Share
LTP Agreement with Men's Health Pharmacy for SPONTAN access
19/12/24	PRICE SENSITIVE	148.1KB	Share
LTP Cleansing Notice
17/12/24		96.46KB	Share
LTP Application for quotation of securities - LTP
17/12/24		15.53KB	Share
LTP Early Launch of Online Mens Health Platform
12/12/24	PRICE SENSITIVE	128.77KB	Share
LTP Change of Company Secretary
11/12/24		75KB	Share
LTP Investor Presentation
10/12/24	PRICE SENSITIVE	2.96MB	Share
LTP Proposed issue of securities - LTP
10/12/24		15.7KB	Share
LTP LTR Pharma Announces Successful A$25 million Placement
10/12/24	PRICE SENSITIVE	141.72KB	Share
LTP Change of Director's Interest Notices
09/12/24		608.08KB	Share
LTP Notification regarding unquoted securities - LTP
09/12/24		18.85KB	Share
LTP Trading Halt
06/12/24	PRICE SENSITIVE	524.84KB	Share
LTP Ord Minnett Biotechnology Conference Presentation
28/11/24		1.87MB	Share
LTP Results of Meeting
27/11/24		92.61KB	Share
LTP AGM Presentation
27/11/24		1.59MB	Share
LTP JV with Leading Men's Health Group for Online Platform
12/11/24	PRICE SENSITIVE	146.82KB	Share
LTP Annual Report to shareholders
28/10/24		2.7MB	Share
LTP Notice of Annual General Meeting/Proxy Form
28/10/24		398.61KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
28/10/24	PRICE SENSITIVE	335.55KB	Share
LTP SPONTAN Final Study Results
14/10/24	PRICE SENSITIVE	148.78KB	Share
LTP Appendix 4G and Corporate Governance Statement
30/08/24		449.98KB	Share
LTP FY24 Results Announcement
30/08/24	PRICE SENSITIVE	126.85KB	Share
LTP Appendix 4E and Annual Financial Report
30/08/24	PRICE SENSITIVE	2.08MB	Share
LTP SPONTAN Prescribed to First Patient by Authorised Prescriber
16/08/24	PRICE SENSITIVE	146.22KB	Share
LTP LTP Secures Global CoDevelopment Agreement with Aptar Pharma
13/08/24	PRICE SENSITIVE	129.33KB	Share
LTP Mens Health Expert Prescribes SPONTAN
08/08/24	PRICE SENSITIVE	157.72KB	Share
LTP SPONTAN prescribed to First Patient Under TGA
05/08/24	PRICE SENSITIVE	162.37KB	Share
LTP Cleansing Notice
31/07/24		77.2KB	Share
LTP Application for quotation of securities - LTP
31/07/24		15.53KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/24	PRICE SENSITIVE	293.5KB	Share
LTP Investor Webinar
24/07/24		79.53KB	Share
LTP Investor Presentation
24/07/24	PRICE SENSITIVE	2.56MB	Share
LTP Proposed issue of securities - LTP
24/07/24		15.29KB	Share
LTP LTR Pharma completes A$10.5 million placement
24/07/24	PRICE SENSITIVE	136.66KB	Share
LTP Trading Halt
22/07/24	PRICE SENSITIVE	162.76KB	Share
LTP Reinstatement to quotation
07/06/24	PRICE SENSITIVE	85.61KB	Share
LTP SPONTAN achieves positive clinical study results
07/06/24	PRICE SENSITIVE	209.2KB	Share
LTP Suspension from Quotation
06/06/24	PRICE SENSITIVE	163.11KB	Share
LTP Trading Halt
04/06/24	PRICE SENSITIVE	194.58KB	Share
LTP Response to ASX Price Query
22/05/24	PRICE SENSITIVE	235.89KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	311.04KB	Share
LTP Notification regarding unquoted securities - LTP
18/04/24		23.65KB	Share
LTP Final Patients dosed in SPONTAN pivotal study
25/03/24	PRICE SENSITIVE	133.61KB	Share
LTP First patients dosed in SPONTAN pivotal study
19/03/24	PRICE SENSITIVE	156.8KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 41.0¢		Change 0.015(3.80%)		Mkt cap ! $71.80M

Open	High	Low	Volume
40.0¢	41.5¢	40.0¢	105.4K

Buyers (Bids)

Vol.	Price($)
2463	40.5¢

Sellers (Offers)

Price($)	Vol.
41.5¢	672

Last trade - 16.10pm 21/04/2026 (20 minute delay)

LTP (ASX) Chart

LTR PHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories